BIOMAT Database Logo BIOMAT Database Logo

Naltrexone treatment of opiate-dependent persons. 1977

L E Hollister, and R L Schwin, and P Kasper

UI MeSH Term Description Entries
D008297 Male Males
D008691 Methadone A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3) Amidone,Biodone,Dolophine,Metadol,Metasedin,Methaddict,Methadone Hydrochloride,Methadose,Methex,Phenadone,Phymet,Physeptone,Pinadone,Symoron,Hydrochloride, Methadone
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D009294 Narcotics Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. Analgesics, Narcotic,Narcotic Analgesics,Narcotic,Narcotic Effect,Narcotic Effects,Effect, Narcotic,Effects, Narcotic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

L E Hollister, and R L Schwin, and P Kasper
Plasma concentrations during naltrexone implant treatment of opiate-dependent patients.
August 2004, British journal of clinical pharmacology,
L E Hollister, and R L Schwin, and P Kasper
[Naltrexone and opiate substitutive treatment].
January 2011, Therapie,
L E Hollister, and R L Schwin, and P Kasper
Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice.
December 2011, Journal of addiction medicine,
L E Hollister, and R L Schwin, and P Kasper
Naltrexone in the treatment of opiate dependence.
May 1987, British journal of hospital medicine,
L E Hollister, and R L Schwin, and P Kasper
Naltrexone in the treatment of opiate dependence.
January 1978, NIDA research monograph,
L E Hollister, and R L Schwin, and P Kasper
A survey of 47 opiate dependent persons who sought treatment.
March 1977, The Medical journal of Malaysia,
L E Hollister, and R L Schwin, and P Kasper
[Detoxification treatment with naltrexone in opiate dependence].
January 1992, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines,
L E Hollister, and R L Schwin, and P Kasper
[Impulsive behaviors in opiate-dependent subjects treated with naltrexone].
January 1994, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines,
L E Hollister, and R L Schwin, and P Kasper
Subcutaneous naltrexone implants reduce opioid use in opiate dependent patients.
February 2010, Evidence-based mental health,
L E Hollister, and R L Schwin, and P Kasper
Naltrexone: a short-term treatment for opiate dependence.
January 1981, The American journal of drug and alcohol abuse,
Copied contents to your clipboard!